Viewing StudyNCT04720131



Ignite Creation Date: 2024-05-06 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04720131
Status: COMPLETED
Last Update Posted: 2024-01-30
First Post: 2021-01-20

Brief Title: Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer
Sponsor:
Organization: Beijing Friendship Hospital